EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Hashimoto Thyroiditis on Long-Term Outcomes in Differentiated Thyroid Carcinoma

Jasna Mihailović iD, Ivana Starčević iD, Slađana Novković-Ostojić, Tijana Vasiljević iD, Nataša Prvulović Bunović, Bojana Šćepanović

Cancers · 14.06.2026 · 18 (12) · 1938

DOI: 10.3390/cancers18121938 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 14.06.2026. Verfasst von Jasna Mihailović und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Molecular Imaging, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Provincial Secretariat for Science and Technological Development, Provincial Secretariat for High Education and Scientific Research, Autonomous Province of Vojvodina, Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hashimoto thyroiditis (HT) coexists with differentiated thyroid carcinoma (DTC), particularly papillary thyroid carcinoma, in approximately 25% of cases. However, the impact of this association on DTC outcomes remains controversial. The aim of this study was to analyze the influence of Hashimoto thyroiditis on disease-specific survival (DSS) and recurrence-free survival (RFS) in DTC patients.

Methods

A retrospective study conducted at our institution between 2007 and 2020 analyzed 707 DTC patients treated with surgery and/or I-131 therapy. Cox proportional hazards regression was used to identify independent predictors, including sex, age, tumor histology, HT status, and initial TNM stage.

Results

Among 707 DTC patients, 628 (88.8%) had papillary cancer, 582 (82.3%) were female, 395 (55.9%) were

Schlagwörter

Stichwörter der Autor:innen

differentiated thyroid carcinomahashimoto thyroiditislong-termoutcome

Autor:innen und Institutionen

  • Department of Nuclear Medicine and Molecular Imaging, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia.
  • Division of Nuclear Medicine, Oncology Institute of Vojvodina, Put dr Goldmana 4, 21204 Sremska Kamenica, Serbia.
  • Radiology Centre, Institute for Pulmonary Diseases of Vojvodina, Put dr Goldmana 4, 21204 Sremska Kamenica, Serbia.
  • Department of Pathology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia.
  • Department of Pathology and Laboratory Diagnostic, Oncology Institute of Vojvodina, Put dr Goldmana 4, 21204 Sremska Kamenica, Serbia.
  • Centre for Diagnostic Imaging, Oncology Institute of Vojvodina, Put dr Goldmana 4, 21204 Sremska Kamenica, Serbia.

ORCID-Profile: Jasna Mihailović, Ivana Starčević, Tijana Vasiljević

Förderung

  • Provincial Secretariat for Science and Technological Development
  • Provincial Secretariat for High Education and Scientific Research, Autonomous Province of Vojvodina, Republic of Serbia

Zitieren

APA

Mihailović, J., Starčević, I., Novković-Ostojić, S., Vasiljević, T., Bunović, N. P., & Šćepanović, B. (2026). Impact of Hashimoto Thyroiditis on Long-Term Outcomes in Differentiated Thyroid Carcinoma. Cancers, 18(12), 1938. https://doi.org/10.3390/cancers18121938

Vancouver

Mihailović J, Starčević I, Novković-Ostojić S, Vasiljević T, Bunović NP, Šćepanović B. Impact of Hashimoto Thyroiditis on Long-Term Outcomes in Differentiated Thyroid Carcinoma. Cancers. 2026;18(12):1938. doi:10.3390/cancers18121938

BibTeX
@article{Mihailovi2026,
  author = {Mihailović, Jasna and Starčević, Ivana and Novković-Ostojić, Slađana and Vasiljević, Tijana and Bunović, Nataša Prvulović and Šćepanović, Bojana},
  title = {Impact of Hashimoto Thyroiditis on Long-Term Outcomes in Differentiated Thyroid Carcinoma},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1938},
  doi = {10.3390/cancers18121938}
}
Kostenlos starten →